|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/30 | |
| A61K 39/395 |
| (11) | Patento numeris | 2490720 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10825726.2 |
| Europos patento paraiškos padavimo data | 2010-10-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-08-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/053686 |
| Data | 2010-10-22 |
| (87) | Numeris | WO 2011/050242 |
| Data | 2011-04-28 |
| (30) | Numeris | Data | Šalis |
| 254474 P | 2009-10-23 | US |
| (72) |
NAM, Samuel, S., US
GREENFIELD, Edward, A., US
BABCOOK, John, CA
O`KEEFE, Theresa, US
QIN, Shixin, US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
Amgen British Columbia, 7990 Enterprise Street, Burnaby, BC V5A 1V7, CA |
| (54) | ANTI-GCC ANTIBODY MOLECULES AND RELATED COMPOSITIONS AND METHODS |
| ANTI-GCC ANTIBODY MOLECULES AND RELATED COMPOSITIONS AND METHODS |